We know your time is precious so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.Image by OpenClipart-Vectors on Pixabay
A family of 12 cybersecurity bugs associated with Bluetooth Low Energy (BLE) may introduce risks for some medical devices. The SweynTooth bugs can't be exploited over the Internet, but a hacker within radio range could launch attacks to crash targeted devices, disable their BLE connection until a restart, or in some cases even bypass BLE's secure pairing mode to take them over. Medical devices like pacemakers and blood glucose monitors are among those most at risk.
After months of rumors, Thermo Fisher Scientific is finally acquiring Qiagen for $11.5 billion. The proposed acquisition is set to close in the first half of 2021. This is one of the largest deals Thermo Fisher Diagnostics has ever been involved with, topping the company’s 13.6 billion acquisition of Life Technologies in 2014.
FDA said it will allow laboratories to begin using coronavirus tests before the agency has completed a review of their emergency use authorization requests. The action is expected to allow the diagnostics industry to respond to the developing situation much more rapidly and effectively.